Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Donut Hole "Down Payment" Added To Combined Senate Health Reform Bill

This article was originally published in The Pink Sheet Daily

Executive Summary

New provision aims to win over seniors while sticking to PhRMA deal. Medicare Part D rebates for dual-eligibles don't make it into Senate compromise.
Advertisement

Related Content

Sens. Baucus, Reid, Dodd Pledge To Close Part D Donut Hole In Conference With House
Sens. Baucus, Reid, Dodd Pledge To Close Part D Donut Hole In Conference With House
Saturday Night Special For Health Reform: Can Senate Coalition Hold?
Saturday Night Special For Health Reform: Can Senate Coalition Hold?
House Leaders Seek GAO Review Of Possible "Anticipatory Price Gouging" By Drug Firms
House Leaders Seek GAO Review Of Possible "Anticipatory Price Gouging" By Drug Firms
House Leaders Seek GAO Review Of Possible "Anticipatory Price Gouging" By Drug Firms
Senate, House Reform Bills Progress; CBO Remains Major Factor In Outcome

Topics

Advertisement
UsernamePublicRestriction

Register

PS068767

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel